These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 32026586

  • 21. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β2-agonist in for patients with asthma.
    Hoshino M, Akitsu K, Ohtawa J.
    J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
    [Abstract] [Full Text] [Related]

  • 22. Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume.
    Pisi R, Aiello M, Calzetta L, Frizzelli A, Alfieri V, Bertorelli G, Pisi G, Chetta A.
    Respiration; 2021 Sep; 100(5):404-410. PubMed ID: 33784705
    [Abstract] [Full Text] [Related]

  • 23. Effect of methacholine on peripheral lung mechanics and ventilation heterogeneity in asthma.
    Downie SR, Salome CM, Verbanck S, Thompson BR, Berend N, King GG.
    J Appl Physiol (1985); 2013 Mar 15; 114(6):770-7. PubMed ID: 23372144
    [Abstract] [Full Text] [Related]

  • 24. An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma.
    Dissanayake S, Jain M, Grothe B, McIver T, Papi A.
    Pulm Pharmacol Ther; 2015 Dec 15; 35():19-27. PubMed ID: 26474679
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S, Terada M, Hozawa M.
    Pulm Pharmacol Ther; 2014 Apr 15; 27(2):190-6. PubMed ID: 24388868
    [Abstract] [Full Text] [Related]

  • 26. Association between peripheral airway function and neutrophilic inflammation in asthma.
    Farah CS, Keulers LA, Hardaker KM, Peters MJ, Berend N, Postma DS, Salome CM, King GG.
    Respirology; 2015 Aug 15; 20(6):975-81. PubMed ID: 25952106
    [Abstract] [Full Text] [Related]

  • 27. Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma.
    Hozawa S, Terada M, Hozawa M.
    Pulm Pharmacol Ther; 2011 Oct 15; 24(5):571-6. PubMed ID: 21624490
    [Abstract] [Full Text] [Related]

  • 28. Small airways dysfunction is associated with increased exacerbations in patients with asthma.
    O'Sullivan CF, Nilsen K, Borg B, Ellis M, Matsas P, Thien F, Douglass JA, Stuart-Andrews C, King GG, Prisk GK, Thompson BR.
    J Appl Physiol (1985); 2022 Sep 01; 133(3):629-636. PubMed ID: 35861519
    [Abstract] [Full Text] [Related]

  • 29. Small airway function before and after cold dry air challenge in pediatric asthma patients during remission.
    Steinbacher M, Pfleger A, Schwantzer G, Jauk S, Weinhandl E, Eber E.
    Pediatr Pulmonol; 2017 Jul 01; 52(7):873-879. PubMed ID: 28486753
    [Abstract] [Full Text] [Related]

  • 30. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A, Balamurugan S, Bardapurkar S, Dalal S, Singh A, Singh BP, Vaidya A, Gogtay JA.
    Pulm Pharmacol Ther; 2018 Feb 01; 48():28-36. PubMed ID: 28890299
    [Abstract] [Full Text] [Related]

  • 31. A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler.
    Latorre M, Paggiaro P, Canonica W, Foschino MP, Papi A.
    Pulm Pharmacol Ther; 2015 Oct 01; 34():31-6. PubMed ID: 26278189
    [Abstract] [Full Text] [Related]

  • 32. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
    Corda L, Gardenghi GG, Modina D, Montemurro LT, Novali M, Tantucci C.
    Allergy Asthma Proc; 2011 Oct 01; 32(6):29-34. PubMed ID: 22221427
    [Abstract] [Full Text] [Related]

  • 33. Single and multiple breath nitrogen washout compared with the methacholine test in patients with suspected asthma and normal spirometry.
    Siebeneichler AS, Schumann DM, Karakioulaki M, Brachsler N, Darie AM, Grize L, Heck TG, Tamm M, Latzin P, Stolz D.
    BMJ Open Respir Res; 2024 May 02; 11(1):. PubMed ID: 38697675
    [Abstract] [Full Text] [Related]

  • 34. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C, De Backer J, Vos W, Marshall J.
    Ther Adv Respir Dis; 2018 May 02; 12():1753466618760948. PubMed ID: 29499614
    [Abstract] [Full Text] [Related]

  • 35. Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Mukhopadhyay A, Waked M, Gogtay J, Gaur V.
    Respir Med; 2020 May 02; 170():106055. PubMed ID: 32843176
    [Abstract] [Full Text] [Related]

  • 36. Forced oscillation technique as a predictor of FEV1 improvement in asthma.
    Akamatsu T, Shirai T, Shimoda Y, Suzuki T, Hayashi I, Noguchi R, Mochizuki E, Sakurai S, Saigusa M, Yamamoto A, Shishido Y, Akita T, Morita S, Asada K.
    Respir Physiol Neurobiol; 2017 Feb 02; 236():78-83. PubMed ID: 27884795
    [Abstract] [Full Text] [Related]

  • 37. Changes in oscillatory impedance and nitrogen washout with combination fluticasone/salmeterol therapy in COPD.
    Timmins SC, Diba C, Schoeffel RE, Salome CM, King GG, Thamrin C.
    Respir Med; 2014 Feb 02; 108(2):344-50. PubMed ID: 24144670
    [Abstract] [Full Text] [Related]

  • 38. Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients.
    Carpagnano GE, Scioscia G, Lacedonia D, Stornelli SR, Irene Quarato CM, Soccio P, Resta O, Foschino Barbaro MP.
    Pulm Pharmacol Ther; 2020 Feb 02; 60():101879. PubMed ID: 31866498
    [Abstract] [Full Text] [Related]

  • 39. Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
    Jarenbäck L, Ankerst J, Bjermer L, Tufvesson E.
    Respir Med; 2016 Jan 02; 110():28-33. PubMed ID: 26607879
    [Abstract] [Full Text] [Related]

  • 40. Small airway function in children with mild to moderate asthmatic symptoms.
    Knihtilä H, Kotaniemi-Syrjänen A, Pelkonen AS, Mäkelä MJ, Malmberg LP.
    Ann Allergy Asthma Immunol; 2018 Oct 02; 121(4):451-457. PubMed ID: 30059790
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.